Selected article for: "domain flexibility and flexible region"

Author: Yuan, Yuan; Cao, Duanfang; Zhang, Yanfang; Ma, Jun; Qi, Jianxun; Wang, Qihui; Lu, Guangwen; Wu, Ying; Yan, Jinghua; Shi, Yi; Zhang, Xinzheng; Gao, George F.
Title: Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
  • Document date: 2017_4_10
  • ID: 094lgjnn_15
    Snippet: Implication for the design of broadly neutralizing antibodies. The S protein is the major antigen on the surface of the MERS-CoV or SARS-CoV virion. For MERS-CoV, most of the currently-available neutralizing antibodies were developed against the flexible RBD region [30] [31] [32] [33] [34] . For SARS-CoV, neutralizing antibodies against both S1 and S2 subunits have been developed 35, 36 . The accessibility of the RBD domain, due to its inherent f.....
    Document: Implication for the design of broadly neutralizing antibodies. The S protein is the major antigen on the surface of the MERS-CoV or SARS-CoV virion. For MERS-CoV, most of the currently-available neutralizing antibodies were developed against the flexible RBD region [30] [31] [32] [33] [34] . For SARS-CoV, neutralizing antibodies against both S1 and S2 subunits have been developed 35, 36 . The accessibility of the RBD domain, due to its inherent flexibility, as shown in this study provides an explanation for the high efficiency of RBD-directed neutralizing antibodies. Since the RBD is located between the NTD domains, a strategy to develop neutralizing antibodies, which target the NTD and interfering with receptor binding through steric hindrance should be feasible in the future.

    Search related documents:
    Co phrase search for related documents
    • broadly neutralize and neutralizing antibody: 1, 2
    • broadly neutralize and RBD domain: 1
    • broadly neutralize antibody and neutralize antibody: 1
    • flexible RBD region and major antigen: 1
    • flexible RBD region and RBD domain: 1, 2
    • flexible RBD region and RBD region: 1, 2
    • high efficiency and major antigen: 1
    • high efficiency and neutralizing antibody: 1, 2, 3, 4
    • high efficiency and RBD domain: 1, 2, 3, 4
    • high efficiency and RBD region: 1
    • high efficiency and receptor bind: 1
    • inherent flexibility and NTD domain: 1
    • inherent flexibility and RBD domain: 1
    • major antigen and neutralizing antibody: 1, 2, 3, 4, 5, 6, 7, 8
    • major antigen and NTD domain: 1, 2, 3
    • major antigen and RBD domain: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • major antigen and RBD region: 1, 2
    • major antigen and receptor bind: 1
    • neutralize antibody and NTD domain: 1